Skip to content
Research Article Open access CC BY 4.0

A Preliminary Study of Serum Osteocalcin in Postmenopausal Women

K. Gurupadappa, Geetha Bhaktha, S. Prashanth, B. Manjula, D. S. Hemantha Kumara

International Journal of Biochemistry Research & Review · pp. 35–40 · Published 15 Apr 2022

10.9734/ijbcrr/2022/v31i230305

Abstract

Osteocalcin is a product of osteoblasts that is considered a marker of bone formation. However, osteocalcin is also released from the bone matrix into the blood during bone resorption, suggesting that osteocalcin is also a marker of bone turnover. Studies on this marker have shown both favoring and contradicting reports about different levels of osteocalcin and Alkaline Phosphate (ALP) among postmenopausal women. Aim and Objective: To determine the diagnostic use of Osteocalcin and ALP in post-menopausal women and to evaluate the association of osteocalcin in postmenopausal women. Materials and Methods: This was a cross-sectional study with two groups of postmenopausal women. Group I of 10 subjects within first 5 yr after the onset of menopause and Group II of 8 subjects following 5yr or more after the onset of menopause. Serum uncarboxylated Osteocalcin, carboxylated Osteocalcin and ALP were estimated using the ELISA technique. Results: The serum ALP, carboxylated Osteocalcin(C-OC), uncarboxylated Osteocalcin (Uc-OC) values were higher in post-menopausal < 5years than those in > 5 years. ALP values correlated positively with C-OC but negatively with PM more >5 years(r=0.159: r= -0.369) Conclusion: Bone turnover gets higher as the years progress among the post-menopausal state which is reflected in ALP, Uc-OC and C-OC. More insight into this state is required to be studied with larger sample size.

ALP bone marker osteocalcin postmenopause

References (15)

  1. 1 European guidance for the diagnosis and management of osteoporosis in postmenopausal women [DOI]
  2. 2 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.
  3. 3 Increased bone formation in osteocalcin-deficient mice [DOI]
  4. 4 Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. [DOI]
  5. 5 Osteocalcin. Biochemical considerations and clinical applications
  6. 6 Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women [DOI]
  7. 7 Age-related changes in trabecular bone microstructures: global and local morphometry [DOI]
  8. 8 European guidance for the diagnosis and management of osteoporosis in postmenopausal women [DOI]
  9. 9 Immunocytochemical demonstration of extracellular matrix proteins in isolated osteocytes [DOI]
  10. 10 Diagnostic Utility of Osteocalcin, Undercarboxylated Osteocalcin, and Alkaline Phosphatase for Osteoporosis in Premenopausal and Postmenopausal Women [DOI]
  11. 11 The menopause and osteoporosis [DOI]
  12. 12 Association of serum undercarboxylated osteocalcin with serum estradiol in pre-, peri- and early post-menopausal women [DOI]
  13. 13 Preventing male osteoporosis: prevalence, risks, diagnosis and imaging tests [DOI]
  14. 14 Evaluation of the relative rates of bone mineral content loss in postmenopause due to both estrogen deficiency and ageing.
  15. 15 Immunocytochemical demonstration of extracellular matrix proteins in isolated osteocytes [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

13

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.